From: The impact of patient preference on dialysis modality and hemodialysis vascular access
Variable | HD (190) | HHD (14) | PD (95) | Total (299) | P value |
---|---|---|---|---|---|
Age, years (SD) | 70.3 (11.6) | 61.9 (10.7) | 67.9 (13.8) | 69.1 (12.4) | 0.024 |
Males, n (%) | 119 (62.6) | 11 (78.6) | 48 (50.5) | 178 (59.5) | 0.048 |
Diabetes mellitus, n (%) | 120 (63.2) | 9 (64.3) | 56 (58.9) | 185 (61.9) | 0.77 |
Coronary artery disease, n (%) | 83 (45.4) | 3 (21.4) | 29 (30.5) | 115 (39.4) | 0.021 |
Previous stroke, n (%) | 39 (21.0) | 0 (0) | 14 (14.7) | 53 (18.0) | 0.087 |
Congestive heart failure, n (%) | 61 (32.8) | 0 (0) | 11 (11.6) | 72 (24.4) | <0.001 |
Weight, kg (SD) | 87.1 (21.1) | 97.5 (30.6) | 82.0 (18.1) | 85.9 (21.0) | 0.017 |
Ethnicity, n (%) | |||||
Caucasian | 161 (84.7) | 12 (85.7) | 81 (85.3) | 254 (84.9) | |
Afro-Canadian | 13 (6.8) | 0 (0) | 4 (4.2) | 17 (5.7) | 0.72 |
Aboriginal | 6 (3.2) | 1 (7.1) | 2 (2.1) | 9 (3.0) | |
Other | 10 (5.3) | 1 (7.1) | 8 (8.4) | 19 (6.4) | |
Creatinine, μmol/L (IQR)a | 524.5 (431.8, 524.5) | 624.5 (486.0, 733.5) | 446.0 (398.0, 532.0) | 500.0 (418.0, 629.0) | <0.001 |
eGFR, ml/min/1.73 m2 (SD) | 9.2 (3.6) | 8.3 (3.2) | 9.9 (3.0) | 9.4 (3.4) | 0.10 |
Albumin, g/L (SD) | 35.2 (4.9) | 37.5 (6.2) | 36.8 (4.5) | 35.9 (5.0) | 0.013 |
eGFR decrease, | |||||
ml/min/1.73 m2/year (IQR)a,b | 3.2 (1.7, 5.5) | 5.1 (2.7, 7.4) | 3.7 (2.3, 5.4) | 3.5 (1.9, 5.6) | 0.056 |
Time- Entry to decision, days (IQR)a | 147.5 (65.0, 359.3) | 241.0 (42.5, 449.0) | 108.0 (39.0, 190.0) | 127.0 (49.0, 273.0) | 0.011 |
Time-Decision to initiation, days (IQR)a | 391.0 (139.0, 797.3) | 436.0 (135.3, 589.0) | 265.0 (146.0, 519.0) | 323.0 (141.0, 731.0) | 0.38 |
Distance to nearest HD unit, km (IQR)a | 5.2 (2.5, 9.0) | 5.6 (3.8, 16.5) | 6.1 (3.0, 12.6) | 5.5 (2.6, 9.4) | 0.35 |